Therapeutic Asset Ratings
461 results matching 1 filter
129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
pf-07934040
Colorectal Neoplasm
Pfizer
P1
C
(39)
pf-07985045
Colorectal Neoplasm
Pfizer
P1
C
(39)
pf-08032562
Breast Cancer
Pfizer
P1
C
(39)
pf-08046031
Metastatic Melanoma
Pfizer
P1
C
(39)
pf-08046032
Diffuse Large B-Cell Lymphoma
Pfizer
P1
C
(39)
pf-08046032
Peripheral T-Cell Lymphoma, Not Otherwise Specified
Pfizer
P1
C
(39)
pf-08046876
Urinary Bladder Carcinoma
Pfizer
P1
C
(39)
pf-08046876
Esophageal Adenocarcinoma
Pfizer
P1
C
(39)
pf-08046876
Esophageal Squamous Cell Carcinoma
Pfizer
P1
C
(39)
pf-08046876
Gastroesophageal Junction Adenocarcinoma
Pfizer
P1
C
(39)
pf-08046876
Head And Neck Cancer
Pfizer
P1
C
(39)
pf-08046876
Pancreatic Adenocarcinoma
Pfizer
P1
C
(39)
pf-08046876
Urothelial Carcinoma
Pfizer
P1
C
(39)
(+)-VINCRISTINE
Advanced or Metastatic Solid Tumors
Pfizer
P1
C
(39)
Maplirpacept
Non-Hodgkin Lymphoma
Pfizer
P1
C
(38)
Maplirpacept
Epithelial Ovarian Cancer
Pfizer
P1/2
C
(38)
Maplirpacept
Ovarian Neoplasm
Pfizer
P1/2
C
(38)
Sasanlimab
Cancer
Pfizer
P1/2
C
(38)
ARRY-558
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(37)
Claturafenib
Melanoma
Pfizer
P1
C
(37)
pf-07224826
Neoplasm
Pfizer
P1
C
(37)
pf-07260437
Breast Neoplasm
Pfizer
P1
C
(37)
pf-07263689
Melanoma
Pfizer
P1
C
(37)
pf-07265028
Gastric Cancer
Pfizer
P1
C
(37)
pf-07265028
Non-Small Cell Lung Carcinoma
Pfizer
P1
C
(37)
Showing 376 to 400 of 461 assets
Previous
Page 16 of 19
Next